MENU
UTHR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
United Therapeutics (UTHR) Ownership - Who owns United Therapeutics?
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
14.37B
P/E Ratio
12.99
Total Cash
3.33B
Projected Growth
0.73
Total Debt
400M
Revenue
2.76B
Risk (Beta)
0.62
Dividend Yield
N/A
Total Cash/Share
74.07
Total Debt/Equity
21.97
Revenue/Share
59.33 USD as % of share price
Fundamentals
UTHR
Capitalization
14.4B
P/E Ratio
12.99
Risk (Beta)
0.62
Dividend Yield
N/A
Total Cash
3.33B
Total Cash/Share
74.07
Total Debt
400M
Total Debt/Equity
21.97
Projected Growth (PEG Ratio)
0.73
Revenue/Share (as % of the share price)
59.33%
Revenue
2.76B
ROE
N/A
Book Value
6.1B
P/B Ratio
2.23
Cash Flow
N/A
Earnings
24.33
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
700K
Current Ratio
4.58
Current Revenue Per Employee
641181.50
Dividends Per Share - Security
N/A
EBITDA
1.55B
Float
N/A
Float - Current
N/A
Gross Income Margin
88.90
Revenue To Assets
15.71
Shares Held By Institutions
37.6B
Shares Outstanding - Current
44.9M
Total Liabilities
1.02B
Total Volume MTD
N/A
Value
N/A
Gain YTD
-12.289
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com